Metoprolol Succinate Tablet, Extended Release
Product Images NDC 72516-032

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Metoprolol Succinate (NDC 72516-032). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Oryza Pharmaceuticals, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure001)

Chemical structure of Metoprolol Succinate, showing the molecular arrangement of atoms including a phenyl ring, hydroxyl groups, ether linkages, and the succinate moiety.*

FDA Label Image

Figure (Figure001)

A forest plot chart displaying results for subgroups in the MERIT-HE study comparing Metoprolol Succinate Extended-Release Tablets to placebo. It shows relative risk and 95% confidence intervals across subgroups for three outcomes: Total Mortality, Total Mortality or All-Cause Hospitalization (time to first event), and Total Mortality or Hospitalization for Heart Failure (time to first event). Subgroups include US vs Non-US, NYHA classifications, ejection fraction, etiology, sex, race, prior myocardial infarction, diabetes status, hypertension status, and heart rate.*

FDA Label Image

Label (Image0001)

Label for Metoprolol Succinate Extended-Release Tablets, 25 mg strength, packaged as 100 tablets. The label includes storage instructions, dosage form, manufacturer Oryza Pharmaceuticals, Inc., and a barcode. It specifies the medication is for oral use and prescription only.*

FDA Label Image

Label (Image0002)

Label for Metoprolol Succinate Extended-Release Tablets 50 mg by Oryza Pharmaceuticals, Inc. The label shows the strength as 50 mg, the quantity as 100 tablets, and includes storage instructions, a warning to keep out of reach of children, and manufacturer information including Oryza Pharmaceuticals, Inc. and Visum Pharmaceutical Co., Ltd.*

FDA Label Image

Label (Image0003)

Metoprolol Succinate Extended-Release Tablets 100 mg, oral dosage form, presented in a 100 tablet package. The label includes dosage details, storage instructions, and manufacturing information by Oryza Pharmaceuticals, Inc. and Visum Pharmaceutical Co., Ltd. The packaging is white with black text and a green highlight for the strength, along with the NDC 72516-032-01.*

FDA Label Image

Label (Image0004)

Label for Metoprolol Succinate Extended-Release Tablets 200 mg, oral dosage form, containing 100 tablets. The label includes storage instructions, manufacturer's details (Oryza Pharmaceuticals, Inc.), and a barcode. The product is prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.